Abstract:The pacemaker of the 1980s is designed to maintain atrioventricular synchrony through dual-chamber pacing. This pacemaker is multiprogrammable and capable of telemetric transmission of biologic, electronic and electrophysiologic data. Several developments have made this therapeutic modality possible: 1) the cumulative survival rate of many lithium-battery pacemakers exceeds 95% at 5 years; 2) lead and connector problems are rare; 3) atrial and ventricular electrode malfunctions occur in less than 2% of implants; and 4) new introducer techniques have simplified implantation (mortality and major morbidity rates are 0.5 and 0.4%, respectively). With multiprogrammability, pacemaker function can be optimized for the patient's needs, and about 20% of reoperations can be avoided. Ninety-six dual-chamber (DDD) pacemakers, 55 of which have been followed up for more than 3 months, have provided trouble-free performance and have yielded salutary clinical results, particularly when implanted to replace previous ventricular inhibited units. Problems with these pacemakers have included unusual pacing electrocardiograms, pacemaker eccentricities, programmer maintenance, pacing and follow-up complexities and costs. In the 1980s, effort will be required to find a balance between rapidly evolving technology and the clinical need for complex pacing systems. From 1978 to 1981, the rate of pacemaker implantation grew from 309 to 513 implants per million population per year, and there are now approximately 500,000 patients with implanted pacemakers living in the United States. Indications for pacing are ill-defined, because in many cases the assessment of clinical response to pacing is largely subjective, lacking satisfactory quantitative indexes. This decade will be a time of reappraisal of the extent of clinical applicability of new techniques, particularly the multiprogrammable dual-chamber system which, after 3 years of clinical trial, shows promise of being the predominant pacemaker of the immediate future.

Physiological Pacing and Its Clinical Application

Cardiac Pacemaker Survey-Twenty Hospitals Pacemaker Implantation Registry in China

The Prophylactic Effect of Special Pacing Therapy on Paroxysmal Atrial Fibrillation

Pacing sites and modes in cardiac resynchronization therapy]

Advances in pacing-induced cardiomyopathy

Comparison Of Synchronization Between Left Bundle Branch And His Bundle Pacing In Atrial Fibrillation Patients: An Intra-Patient-Controlled Study

Effect of Atrial Pacing Therapy with Selective Pacing Algorithms on Paroxysmal Atrial Fibrillation.

A Multi-Lead ECG Monitoring Combined with a Programmed Intracavitary ECG to Complete LBBaP Pacing: Study Protocol for a Single-center, Prospective Study

Anatomical and Histological Assessment of Left Bundle Branch Area Pacing in Human Heart with Refractory Heart Failure

Electrophysiological Insights into Three Modalities of Left Bundle Branch Area Pacing in Patients Indicated for Pacing Therapy

Electrical Synchrony Optimization for Left Bundle Branch Area Pacing in Patients with Bradycardia and Heart Failure.

Cardiovascular imaging in conduction system pacing: What does the clinician need?

Physiological pacing: just a lot of buzz or the next paradigm shift in bradycardia pacing?

Influences of Different Modes of Pacing on Heart Function: Retrospective Analysis of 306 Patients

Comparing Different Activation Patterns in a Physiological Pacing Case: Insights from High-Resolution Mapping.

Effect of heart pacemaker on preventing and terminating chronic arrhythmia and its influence on cardiac function

A Computer Simulation Research of Two Types of Cardiac Physiological Pacing

Cardiac pacing in the 1980s: treatment and techniques in transition

The Overview of Rate-adaptation in Cardiac Pacemakers

Left Bundle Branch Area Pacing Leading the Way: Emerging Trends in Cardiac Pacing

Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing